This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2012 Feb 25;379(9817):710-1; author reply 711-2.

doi: 10.1016/S0140-6736(12)60304-3.

Side-effects of roflumilast

PMID: 22364756
DOI: 10.1016/S0140-6736(12)60304-3

Comment

Side-effects of roflumilast

Steve Gupta. Lancet. 2012.

. 2012 Feb 25;379(9817):710-1; author reply 711-2.

doi: 10.1016/S0140-6736(12)60304-3.

Author

PMID: 22364756
DOI: 10.1016/S0140-6736(12)60304-3

No abstract available

PubMed Disclaimer

Comment on

Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials.
Calverley PM, Rabe KF, Goehring UM, Kristiansen S, Fabbri LM, Martinez FJ; M2-124 and M2-125 study groups. Calverley PM, et al. Lancet. 2009 Aug 29;374(9691):685-94. doi: 10.1016/S0140-6736(09)61255-1. Lancet. 2009. PMID: 19716960 Clinical Trial.
Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials.
Fabbri LM, Calverley PM, Izquierdo-Alonso JL, Bundschuh DS, Brose M, Martinez FJ, Rabe KF; M2-127 and M2-128 study groups. Fabbri LM, et al. Lancet. 2009 Aug 29;374(9691):695-703. doi: 10.1016/S0140-6736(09)61252-6. Lancet. 2009. PMID: 19716961 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information